1. Medtech Insight
  2. >>Archive

Ophthalmic Imaging Systems set for MediVision merger

Digital imaging specialist Ophthalmic Imaging Systems (OIS) is set to merge with Israeli firm MediVision Medical Imaging in a stock-for-stock transaction. The merger, which is expected to close during the third quarter of 2008, will see each MediVision share be converted into 1.66 shares of OIS common stock, for a total of 11.3 million OIS shares. The deal sees Yokneam Elit-based MediVision - OIS' majority shareholder prior to the transaction - become a subsidiary of OIS.

Digital imaging specialist Ophthalmic Imaging Systems (OIS) is set to merge with Israeli firm MediVision Medical Imaging in a stock-for-stock transaction. The merger, which is expected to close during the third quarter of 2008, will see each MediVision share be converted into 1.66 shares of OIS common stock, for a total of 11.3 million OIS shares. The deal sees Yokneam Elit-based MediVision - OIS' majority shareholder prior to the transaction - become a subsidiary of OIS.

OIS (Sacramento, California) will gain MediVision's product pipeline of digital eyecare equipment, its R&D, sales and distribution capabilities, and its...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

HistoSonics’ Edison System Gains Limited UK Access, While Awaiting CE Marking

 
• By Shubham Singh

While HistoSonics is awaiting the CE mark in Europe, it hit a major milestone by securing early limited market access in Great Britain under a Unmet Clinical Need Authorization (UCNA), bringing its noninvasive histotripsy treatment to patients with liver tumors.

Medtech Giants Brace for Tariffs Impact: Responses Range From Financial To Philosophical

 
• By Marion Webb, Shubham Singh, and Nancy Pham

Manufacturing shifts, financial planning, and supply chain changes are among the adjustments that medtech leaders are making to Trump-era tariffs. Medtech Insight’s review of first-quarter earnings calls reveals how firms are navigating the impact and uncertainty of evolving trade policies.

Global Medtech Guidance Tracker: May 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.